MFS
ITCI

Mirabella Financial Services’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Mirabella Financial Services’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-9,630
Closed -$660K – 478
2024
Q2 		$660K Buy
+9,630
New +$668K 0.05% 219
2023
Q2 		– Sell
-6,267
Closed -$4.02M – 694
2023
Q1 		$4.02M Sell
6,267
-36,618
-85% -$1.77M 0.61% 50
2022
Q4 		$2.27M Buy
42,885
+20,167
+89% +$1.01M 0.2% 84
2022
Q3 		$1.06M Buy
+22,718
New +$1.19M 0.11% 105

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mirabella Financial Services's ITCI Position: Q3 2024 in Review

Mirabella Financial Services sold out of Intra-Cellular Therapies Inc. (ITCI) in Q3 2024, closing a stake of 9,630 shares — an estimated $660K sold.

Mirabella Financial Services first reported a position in ITCI in Q3 2022 and held it in 4 quarters. The position peaked at $4.02M in Q1 2023. 355 funds tracked by Wall St. Rank hold ITCI as of Q3 2024.

  • Mirabella Financial Services reported no remaining Intra-Cellular Therapies Inc. position as of Q3 2024 after selling out during the quarter.
  • Mirabella Financial Services sold 9,630 Intra-Cellular Therapies Inc. shares in Q3 2024, an estimated $660K.
  • Mirabella Financial Services first reported a position in Intra-Cellular Therapies Inc. in Q3 2022 and held it in 4 quarters.
  • Mirabella Financial Services's Intra-Cellular Therapies Inc. position peaked at $4.02M in Q1 2023.
  • 355 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q3 2024.

Based on Mirabella Financial Services's 13F filing for Q3 2024, filed 13 Nov 2024.